The shares of Torrent Pharmaceuticals Ltd gave multibagger returns in the past twenty years as they appreciated by 12,998.24% from ₹ 11.91 to ₹ 1560.00 apiece! This explains why staying invested in a company for the long term can pay off really well.
If an investor had invested ₹ 1,00,000 in the company’s shares on 12 August 2002, the value of their holdings would have been ₹ 1,06,22,970 today! The shares had reached their 52-week high of ₹ 1,649.25. At that point, the value of the holdings would have been ₹ 1,47,38,610 as the shares gave 14,638.61% in returns.
Torrent Pharmaceuticals Ltd is a leading Indian pharmaceutical company that is engaged in the research, development, manufacturing and marketing of generic pharmaceutical formulations. It is the flagship company of Torrent Group which also has a presence in power and city gas distribution businesses.
It is a large-cap company with a market capitalization of ₹ 52,403 crores. It is trading at a PE Ratio (TTM) of 65.48, higher than the sector PE of 30.35. This means that investors are expecting high growth rates in the future or that the company’s stock is overvalued. It has an ideal debt-to-equity ratio of 0.67. It has a dividend yield of 3.10. The company’s promoters hold a 71.25% stake in it.
Prabhudas Lilladher has a buy call on the shares of the company with a target price of ₹ 1750. The time period given by the analyst is one year when its price can achieve the given target. This implies an upside of 13.27%.
Written By Simran Bafna
Disclaimer
The content in this news article is not investment advice. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
